All stock lists
Unlock the score
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
4.18+0.16 (+3.98%)
Market cap
$8.39M
Insider Score
Analyst consensus
Listed since
Aug 1, 2016
Website
Insider Score
/ 100
QNRX Insider Score
Quoin Pharmaceuticals, Ltd. has a live Insider Score.
Scored on 4 qualifying trades from 4 insiders in the last 90 days.
QNRX Stock Insider Trading Activity
QNRX stock’s insider trading shows 4 purchases for an estimated $279.97K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days4 qualifying buys4 insiders$279.97K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Myers Michael CEO | Buy | 20,490 | $4.88 | $99.99K | 119% | 37,713 | Aug 31, 2026 | A+Cluster BuyFirst BuyDilution | Form 4 |
| Carter Denise P. COO | Buy | 20,490 | $4.88 | $99.99K | 119% | 37,709 | Aug 31, 2026 | A+Cluster BuyFirst BuyDilution | Form 4 |
| Lawlor Sally Bridget CFO | Buy | 10,244 | $4.88 | $49.99K | 2328% | 10,684 | Aug 31, 2026 | A+Cluster BuyFirst BuyDilution | Form 4 |
| Culverwell Anthony James Director | Buy | 6,146 | $4.88 | $29.99K | 18.0% | 40,364 | Aug 31, 2026 | CCluster BuyFirst BuyDilution | Form 4 |
| Culverwell Anthony James Director | Award | 31,352 | $5.15 | $161.46K | 1094% | 34,218 | Aug 27, 2026 | — | Form 4 |
| LANGER DENNIS Director | Award | 34,534 | $5.15 | $177.85K | 159% | 56,243 | Aug 27, 2026 | — | Form 4 |
| LANGER DENNIS Director | Buy | 15,152 | $8.49 | $128.64K | 1515200% | 15,153 | Oct 14, 2025 | AFirst BuyStake DoublerDilution | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Award (A) — Grant or award from the company, not a purchase
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.